{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:20:43Z","timestamp":1794025243858,"version":"4.8.0"},"reference-count":23,"publisher":"Royal College of General Practitioners","issue":"720","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Little is known about trends in prescribing of anxiolytics (antidepressants, benzodiazepines, beta-blockers, anticonvulsants, and antipsychotics) for treatment of anxiety. Several changes may have affected prescribing in recent years, including changes in clinical guidance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To examine trends in prescribing for anxiety in UK primary care between 2003 and 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>A population-based cohort study using Clinical Practice Research Datalink (CPRD) data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Analysis of data from adults (<jats:italic>n<\/jats:italic> = 2 569 153) registered at CPRD practices between 2003 and 2018. Prevalence and incidence rates were calculated for prescriptions of any anxiolytic and also for each drug class. Treatment duration was also examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2003 and 2018, prevalence of any anxiolytic prescription increased from 24.9\/1000 person-years-at-risk (PYAR) to 43.6\/1000 PYAR, driven by increases in those starting treatment, rather than more long-term use. Between 2003 and 2006, incidence of any anxiolytic prescription decreased from 12.8\/1000 PYAR to 10.0\/1000 PYAR; after which incidence rose to 13.1\/1000 PYAR in 2018. Similar trends were seen for antidepressant prescriptions. Incident beta-blocker prescribing increased over the 16 years, whereas incident benzodiazepine prescriptions decreased. Long-term prescribing of benzodiazepines declined, yet 44% of prescriptions in 2017 were longer than the recommended 4 weeks. Incident prescriptions in each drug class have risen substantially in young adults in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Recent increases in incident prescribing, especially in young adults, may reflect better detection of anxiety, increasing acceptability of medication, or an earlier unmet need. However, some prescribing is not based on robust evidence of effectiveness, may contradict guidelines, and there is limited evidence on the overall impact associated with taking antidepressants long term. As such, there may be unintended harm.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp.2021.0561","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:40:16Z","timestamp":1643629216000},"page":"e511-e518","source":"Crossref","is-referenced-by-count":30,"title":["Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink"],"prefix":"10.3399","volume":"72","author":[{"given":"Charlotte","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Mars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2022092209350842000_72.720.e511.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"2022092209350842000_72.720.e511.2","unstructured":"National Institute for Health and Care Excellence (2019) Generalised anxiety disorder and panic disorder in adults: management CG113, https:\/\/www.nice.org.uk\/guidance\/cg113 (accessed 2 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-016-1306-4"},{"key":"2022092209350842000_72.720.e511.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3999"},{"issue":"3","key":"2022092209350842000_72.720.e511.5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjp.2020.159","article-title":"Trends in generalised anxiety disorders and symptoms in primary care: UK population-based cohort study","volume":"218","author":"Slee","year":"2021","journal-title":"Br J Psychiatry"},{"key":"2022092209350842000_72.720.e511.6","unstructured":"National Institute for Health and Care Excellence (2014) Anxiety disorders: quality standard QS53, https:\/\/www.nice.org.uk\/guidance\/qs53 (accessed 2 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.7","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"2022092209350842000_72.720.e511.8","unstructured":"National Cancer Institute (2022) Joinpoint trend analysis software. https:\/\/surveillance.cancer.gov\/joinpoint (accessed 2 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.9","doi-asserted-by":"crossref","unstructured":"Lockhart P Guthrie B (2011) Trends in primary care antidepressant prescribing 1995\u20132007: a longitudinal population database analysis. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp11X593848.","DOI":"10.3399\/bjgp11X593848"},{"key":"2022092209350842000_72.720.e511.10","doi-asserted-by":"crossref","unstructured":"Archer C Kessler D Wiles N Turner K (2021) GPs\u2019 and patients\u2019 views on the value of diagnosing anxiety disorders in primary care: a qualitative interview study. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/BJGP.2020.0959.","DOI":"10.3399\/BJGP.2020.0959"},{"issue":"2","key":"2022092209350842000_72.720.e511.11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00127-021-02131-8","article-title":"Trends in the recording of anxiety in UK primary care: a multi-method approach","volume":"57","author":"Archer","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2022092209350842000_72.720.e511.12","unstructured":"(2015) Medicines and Healthcare products Regulatory Agency. Benzodiazepines, https:\/\/cpd.mhra.gov.uk\/benzodiazepines\/CON234573_20 (accessed 2 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.13","unstructured":"openprescribing.net Propranolol hydrochloride (0204000R0). https:\/\/openprescribing.net\/chemical\/0204000R0 (accessed 2 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.14","unstructured":"Royal Pharmaceutical Society of Great Britain (2022) British National Formulary, https:\/\/bnf.nice.org.uk (accessed 2 Mar 2022)."},{"issue":"3","key":"2022092209350842000_72.720.e511.15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2478\/cpp-2018-0017","article-title":"The role of beta-adrenolytic drugs in treating anxiety disorders","volume":"19","author":"Brudkowska","year":"2018","journal-title":"Curr Probl Psychiatry"},{"key":"2022092209350842000_72.720.e511.16","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115612236"},{"key":"2022092209350842000_72.720.e511.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12358"},{"key":"2022092209350842000_72.720.e511.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006135"},{"key":"2022092209350842000_72.720.e511.19","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmp071"},{"key":"2022092209350842000_72.720.e511.20","unstructured":"Public Health England (2019) Dependence and withdrawal associated with some prescribed medicines: an evidence review, https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/940255\/PHE_PMR_report_Dec2020.pdf (accessed 2 Mar 2022)."},{"issue":"4","key":"2022092209350842000_72.720.e511.21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0706743716640757","article-title":"The age of onset of anxiety disorders: a meta-analysis","volume":"62","author":"de Lijster","year":"2017","journal-title":"Can J Psychiatry"},{"key":"2022092209350842000_72.720.e511.22","unstructured":"NHS Digital (2022) Mental health services monthly statistics. Https:\/\/app.powerbi.com\/view?r=eyJrIjoiNzY3ZGJkODMtMmZkZi00MDVlLWIzNDctMWE0ZjNkNjAyY2E2IiwidCI6IjUwZjYwNzFmLWJiZmUtNDAxYS04ODAzLTY3Mzc0OGU2MjllMiIsImMiOjh9 (accessed 7 Mar 2022)."},{"key":"2022092209350842000_72.720.e511.23","unstructured":"Crena-Jennings W Hutchinson J (2020) Access to child and adolescent mental health services in 2019, https:\/\/epi.org.uk\/wp-content\/uploads\/2020\/01\/Access-to-CAMHS-in-2019_EPI.pdf (accessed 2 Mar 2022)."}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2021.0561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T16:44:19Z","timestamp":1663865059000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2021.0561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":23,"journal-issue":{"issue":"720","published-online":{"date-parts":[[2022,6,30]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.3399\/BJGP.2021.0561"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2021.0561","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}